BIOFRONTERA INC BFRI

US Healthcare Pharmaceutical Preparations
$1.01
0.0%
52w: $0.57 – $1.16

Latest 13F among current holders filed 1 month ago (May 15, 2026)

Price — last 12 months

research preview data
0.570.861.16
Jun 20, 2025 Jul 2, 2026
Institutional holders
12
-2 QoQ
13F value
$1.9M
+45.2% QoQ
Smart-money holders
2
signal tier ≥ 2
New smart buyers
0
Q1 2026

Institutional value by quarter

$4.6M
Q1 2024
$1.0M
Q2 2024
$1.4M
Q3 2024
$2.0M
Q4 2024
$1.2M
Q1 2025
$1.5M
Q2 2025
$2.4M
Q3 2025
$1.3M
Q4 2025
$1.9M
Q1 2026

Number of holders

12
Q1 2024
13
Q2 2024
10
Q3 2024
15
Q4 2024
13
Q1 2025
11
Q2 2025
13
Q3 2025
14
Q4 2025
12
Q1 2026

Who owns BFRI?

Q1 2026 filings
FundTypeSharesValue% of fundChange
Rosalind Advisors, Inc. ★2Fundamental concentrated1.2M$942K0.4%+2.0%
AIGH Capital Management LLC ★2Fundamental concentrated915.2K$740K0.2%Held
GEODE CAPITAL MANAGEMENT, LLC Index provider109.3K$88K0.0%+66.4%
VANGUARD FIDUCIARY TRUST CO Diversified mechanical61.7K$50K0.0%
VANGUARD CAPITAL MANAGEMENT LLC Diversified mechanical52.3K$42K0.0%
SUSQUEHANNA INTERNATIONAL GROUP, LLP Market maker38.6K$31K0.0%+234.1%
XTX Topco Ltd Market maker22.5K$18K0.0%+19.2%
CITIGROUP INC Bank broker11.8K$10K0.0%+1183600.0%
Sanctuary Advisors, LLC Wealth advisor10.2K$8K0.0%+1.0%
BlackRock, Inc. Index provider4.6K$4K0.0%Held
UBS Group AG Bank broker1.5K$1K0.0%-85.1%
SBI Securities Co., Ltd. Diversified mechanical305$2470.0%+1.7%

Exits are not a bearish signal: our backtest shows stocks specialists exit keep outperforming for 3+ quarters — selling usually means profit-taking, not a forecast.